Education
About Us
Working with TipRanks
Follow Us
Celularity (CELU)
NASDAQ:CELU
Total Valuation
Celularity has a market cap or net worth of $35.71M. The enterprise value is .
Market Cap$35.71M
Enterprise Value
Share Statistics
Celularity has 23.81M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23.81M
Owened by Insiders47.82%
Owened by Instutions3.84%
Financial Efficiency
Celularity’s return on equity (ROE) is -4.79 and return on invested capital (ROIC) is -166.01%.
Return on Equity (ROE)-479.24%
Return on Assets (ROA)-136.42%
Return on Invested Capital (ROIC)-166.01%
Return on Capital Employed (ROCE)-251.06%
Revenue Per Employee$401,666.667
Profits Per Employee-$292,100
Employee Count120
Asset Turnover0.16
Inventory Turnover2.78
Valuation Ratios
The current PE Ratio of Celularity is -0.22. Celularity’s PEG ratio is <0.01.
PE Ratio-0.22
PS Ratio1.93
PB Ratio1.07
Price to Fair Value1.07
Price to FCF-1.03
Price to Operating Cash Flow-1.14
PEG Ratio<0.01
Income Statement
In the last 12 months, Celularity had revenue of $48.20M and earned -$35.05M in profits. Earnings per share was -$1.52.
Revenue$48.20M
Gross Profit$30.95M
Operating Income-$15.76M
Pretax Income-$35.04M
Net Income-$35.05M
EBITDA-41.73M
Earnings Per Share (EPS)-1.52
Cash Flow
In the last 12 months, operating cash flow was -$12.34M and capital expenditures -$685.00K, giving a free cash flow of -$13.02M billion.
Operating Cash Flow-$12.34M
Free Cash Flow-$13.02M
Free Cash Flow per Share-$0.55
Dividends & Yields
Celularity pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-97.13%
Earnings Yield-446.15%
Stock Price Statistics
Beta4.12
52-Week Price Change-60.95%
50-Day Moving Average1.69
200-Day Moving Average2.39
Relative Strength Index (RSI)50.01
Average Volume (3m)143.03K
Important Dates
Celularity upcoming earnings date is Nov 10, 2023, After Close.
Last Earnings DateAug 14, 2023
Next Earnings DateNov 10, 2023
Ex-Dividend Date―
Financial Position
Celularity as a current ratio of 0.29, with Debt / Equity ratio of 1.60
Current Ratio0.29
Quick Ratio0.21
Debt to Market Cap0.89
Net Debt to EBITDA-0.35
Interest Coverage Ratio-63.78
Taxes
In the past 12 months, Celularity has paid -$13.48M in taxes.
Income Tax-$13.48M
Effective Tax Rate>-0.01%
Enterprise Valuation
Celularity EV to EBITDA ratio is -0.59, with an EV/FCF ratio of -2.56.
EV to Sales4.80
EV to EBITDA-0.59
EV to Free Cash Flow-2.56
EV to Operating Cash Flow-2.82
Balance Sheet
Celularity has $133.00K in cash and marketable securities with $69.06M in debt, giving a net cash position of $68.93M billion.
Cash & Marketable Securities$133.00K
Total Debt$69.06M
Net Cash$68.93M
Net Cash Per Share$2.90
Tangible Book Value Per Share$1.27
Margins
Gross margin is 29.66%, with operating margin of -844.44%, and net profit margin of -862.04%.
Gross Margin29.66%
Operating Margin-844.44%
Pretax Margin-862.00%
Net Profit Margin-862.04%
EBITDA Margin-807.81%
EBIT Margin-848.75%
Analyst Forecast
The average price target for Celularity is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast